PT Charlie Hospital Semarang Tbk (IDX:RSCH)
Indonesia · Delayed Price · Currency is IDR 346.00
+6.00 (1.76%)
Last updated: Aug 27, 2026, 2:43 PM WIB
IDX:RSCH Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 119,462 | 114,397 | 48,502 | 42,160 | 33,033 | 35,558 | |
Revenue Growth | 131.53% | 135.86% | 15.04% | 27.63% | -7.10% | 168.08% |
Cost of Revenue | 96,438 | 96,765 | 35,239 | 30,213 | 29,841 | 20,256 |
Gross Profit | 23,024 | 17,632 | 13,263 | 11,947 | 3,193 | 15,302 |
Selling, General & Admin | 18,532 | 16,966 | 12,367 | 13,364 | 8,049 | 7,982 |
Other Operating Expenses | 2,333 | 2,295 | 969.26 | - | 1,249 | 1,432 |
Operating Expenses | 31,734 | 28,733 | 16,321 | 13,364 | 11,988 | 11,781 |
Operating Income | -8,710 | -11,101 | -3,058 | -1,417 | -8,796 | 3,520 |
Interest Expense | -7,123 | -10,434 | -1,410 | - | - | - |
Interest & Investment Income | 15.73 | 35.51 | 41.84 | 43.25 | 33.57 | 8.91 |
Other Non Operating Income (Expenses) | 1,949 | 597.35 | 361.2 | 61.26 | -152.77 | 21.43 |
EBT Excluding Unusual Items | -13,869 | -20,903 | -4,065 | -1,312 | -8,915 | 3,550 |
Asset Writedown | 3.71 | - | -24.38 | - | - | - |
Pretax Income | -13,865 | -20,903 | -4,090 | -1,312 | -8,915 | 3,550 |
Income Tax Expense | 1,618 | -4,491 | -577.08 | -200.68 | -1,560 | 810.09 |
Earnings From Continuing Operations | -15,483 | -16,412 | -3,512 | -1,112 | -7,355 | 2,740 |
Minority Interest in Earnings | -19.06 | -8.38 | - | - | - | - |
Net Income | -15,502 | -16,420 | -3,512 | -1,112 | -7,355 | 2,740 |
Net Income to Common | -15,502 | -16,420 | -3,512 | -1,112 | -7,355 | 2,740 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2,650 | 2,650 | 2,650 | 2,303 | 1,000 | 1,000 |
Shares Outstanding (Diluted) | 2,650 | 2,650 | 2,650 | 2,303 | 1,000 | 1,000 |
Shares Change | - | - | 15.05% | 130.33% | - | 1923.39% |
EPS (Basic) | -5.85 | -6.20 | -1.33 | -0.48 | -7.35 | 2.74 |
EPS (Diluted) | -5.85 | -6.20 | -1.33 | -0.48 | -7.35 | 2.74 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 47,744 | -49,767 | -40,212 | -62,216 | -16,095 | -12,011 |
Free Cash Flow Per Share | 18.02 | -18.78 | -15.17 | -27.01 | -16.09 | -12.01 |
Gross Margin | 19.27% | 15.41% | 27.35% | 28.34% | 9.66% | 43.03% |
Operating Margin | -7.29% | -9.70% | -6.31% | -3.36% | -26.63% | 9.90% |
Profit Margin | -12.98% | -14.35% | -7.24% | -2.64% | -22.26% | 7.71% |
Free Cash Flow Margin | 39.97% | -43.50% | -82.91% | -147.57% | -48.72% | -33.78% |
EBITDA | -356.39 | 8,757 | 5,409 | 4,322 | -3,287 | 7,916 |
EBITDA Margin | -0.30% | 7.66% | 11.15% | 10.25% | -9.95% | 22.26% |
D&A For EBITDA | 8,354 | 19,858 | 8,467 | 5,739 | 5,509 | 4,396 |
EBIT | -8,710 | -11,101 | -3,058 | -1,417 | -8,796 | 3,520 |
EBIT Margin | -7.29% | -9.70% | -6.31% | -3.36% | -26.63% | 9.90% |
Effective Tax Rate | - | - | - | - | - | 22.82% |